Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4

Journal of Immunology

Volumn 167, Issue 4, 2001, Pages 2250-2256

  Supajatura, V ^a   Ushio, H ^a   Nakao, A ^a   Okumura, K ^a   Ra, C ^a   Ogawa, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; GRAM NEGATIVE INFECTION; IMMUNOREACTIVITY; INFECTION RESISTANCE; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035881267     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.4.2250     Document Type: Article

References (46)

1. Interleukin-3 dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines
2. Mast cell phagocytosis of FimH-expressing enterobacteria
3. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells
4. The two faces of the mast cell
5. Critical protective role of mast cells in a model of acute septic peritonitis
6. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
7. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis
8. Innate immunity: Impact on the adaptive immune response
9. Toll signaling pathways in the innate immune response
10. The Toll-receptor family and control of innate immunity
11. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components
12. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2
13. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
14. Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin
15. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
16. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
17. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
18. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
19. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
20. v mice: Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells
21. Clonal assay of mouse mast cell colonies in methylcellulose culture
22. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophage: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression
23. Cloning and characterization of the murine Toll-like receptor 5 (TLR 5) gene: Sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice
24. TLR6: A novel member of an expanding Toll-like receptor family
25. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions
26. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
27. Immunologic release of β-hexosaminidase and β-glucuronidase from purified rat serosal mast cells
28. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors
29. The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)
30. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages
31. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses
32. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
33. Proinflammatory cytokines
34. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
35. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
36. Molecular and biological characteristics of interleukin-13
37. Expression and contribution of endogenous IL-13 in an experimental model of sepsis
38. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide
39. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades
40. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein
41. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14
42. Soluble CD14 participates in the response of cells to lipopolysaccharide
43. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
44. Analyzing mast cell development and function using mice carrying mutation at W/c-kit or SI/MGF (SCF) loci
45. In vivo immunological function of mast cells derived from embryonic stem cells: An approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo
46. Impaired mast cell-dependent natural immunity in complement C3-deficient mice